Effective management of recurrent Doege–Potter syndrome with somatostatin‐analogues: A case report

Effective management of recurrent Doege–Potter syndrome with somatostatin‐analogues: A case report

Abstract Background Doege–Potter syndrome is defined as paraneoplastic hypoinsulinemic hypoglycemia associated with a benign or malignant solitary fibrous tumor frequently located in pleural, but also extrapleural sites. Hypoglycemia can be attributed to paraneoplastic secretion of “Big‐IGF‐II,” a p...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Felix Schöler, Maximilian Andreas Storz, Ashkan Khavaran, Nicolas Hümmler, Maximilian Frederik Russe, Christoph‐Ferdinand Wielenberg, Katharina Laubner, Jochen Seufert
פורמט: Article
שפה:English
יצא לאור: Wiley 2024-03-01
סדרה:Cancer Reports
נושאים:
debulking surgery
Doege–Potter syndrome
insulin‐like growth factor II
Lanreotide
Octreotide
solitary fibrous tumor
גישה מקוונת:https://doi.org/10.1002/cnr2.1992

אינטרנט

https://doi.org/10.1002/cnr2.1992

פריטים דומים